Neutrophil CD40 enhances platelet-mediated inflammation

Thrombosis Research

Volumn 122, Issue 3, 2008, Pages 346-358

  Vanichakarn, Pantila ^a   Blair, Price ^a   Wu, Cindy ^a   Freedman, Jane E ^a   Chakrabarti, Subrata ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD40; Neutrophil platelet conjugate; Neutrophils; Platelets; ROS; sCD40L

Indexed keywords

CD40 ANTIGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE RELEASE REACTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD40; BLOOD PLATELETS; BLOTTING, WESTERN; CD40 LIGAND; CELL COMMUNICATION; HUMANS; INFLAMMATION; NEUTROPHILS; PLATELET ACTIVATION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES;

EID: 45849149667     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.12.019     Document Type: Article

References (48)

1. von Hundelshausen P., and Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100 (2007) 27-40
2. Gawaj M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-33784
3. Inoue T., Komoda H., Kotooka N., Morooka T., Fujimatsu D., Hikichi Y., et al. Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis 196 1 (2007) 469-476
4. Inoue T., Kato T., Hikichi Y., Hashimoto S., Hirase T., Morooka T., et al. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost 95 (2006) 43-48
5. Dang P.M., Stensballe A., Boussetta T., Raad H., Dewas C., Kroviarski Y., et al. A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 116 (2006) 2033-2043
6. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108 (2006) 2455-2462
7. Andre P., Nannizzi-Alaimo L., Prasad S.K., and Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106 (2002) 896-899
8. Urbich C., and Dimmeler S. CD40 and vascular inflammation. Can J Cardiol 20 (2004) 681-683
9. Pluvinet R., Petriz J., Torras J., Herrero-Fresneda I., Cruzado J.M., Grinyo J.M., et al. RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. Blood 104 (2004) 3642-3646
10. Chakrabarti S., Blair P., and Freedman J.E. CD40-40L signaling in vascular inflammation. J Biol Chem 282 (2007) 18307-18317
11. van Kooten C., Gaillard C., Galizzi J.P., Hermann P., Fossiez F., Banchereau J., et al. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 24 (1994) 787-792
12. Spriggs M.K., Armitage R.J., Strockbine L., Clifford K.N., Macduff B.M., Sato T.A., et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176 (1992) 1543-1550
13. Kroczek R.A., Graf D., Brugnoni D., Giliani S., Korthuer U., Ugazio A., et al. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol Rev 138 (1994) 39-59
14. Gauchat J.F., Aubry J.P., Mazzei G., Life P., Jomotte T., Elson G., et al. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett 315 (1993) 259-266
15. Henn V., Steinbach S., Buchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
16. Hermann A., Rauch B.H., Braun M., Schror K., and Weber A.A. Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 12 (2001) 74-82
17. Viallard J.F., Solanilla A., Gauthier B., Contin C., Dechanet J., Grosset C., et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 99 (2002) 2612-2614
18. Inwald D.P., McDowall A., Peters M.J., Callard R.E., and Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92 (2003) 1041-1048
19. Freedman J.E., and Keaney Jr. J.F. Nitric oxide and superoxide detection in human platelets. Methods Enzymol 301 (1999) 61-70
20. Freedman J.E., Farhat J.H., Loscalzo J., and Keaney Jr. J.F. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94 (1996) 2434-24340
21. Freedman J.E., Loscalzo J., Benoit S.E., Valeri C.R., Barnard M.R., and Michelson A.D. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest 97 (1996) 979-987
22. Freedman J.E., Loscalzo J., Barnard M.R., Alpert C., Keaney J.F., and Michelson A.D. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100 (1997) 350-356
23. Chakrabarti S., Varghese S., Vitseva O., Tanriverdi K., and Freedman J.E. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 25 (2005) 2428-2434
24. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger III A.L., and Furman M.I. Evaluation of platelet function by flow cytometry. Methods 21 (2000) 259-270
25. Linden M.D., Frelinger III A.L., Barnard M.R., Przyklenk K., Furman M.I., and Michelson A.D. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30 (2004) 501-511
26. Sahin G., Yalcin A.U., and Akcar N. Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients. Blood Purif 25 (2007) 309-315
27. Amer J., Goldfarb A., and Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 60 (2004) 73-80
28. Amer J., Weiss L., Reich S., Shapira M.Y., Slavin S., and Fibach E. The oxidative status of blood cells in a murine model of graft-versus-host disease. Ann Hematol 86 (2007) 753-758
29. Han D., Handelman G., Marcocci L., Sen C.K., Roy S., Kobuchi H., et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6 (1997) 321-338
30. Patel M.S., and Hong Y.S. Lipoic acid as an antioxidant. The role of dihydrolipoamide dehydrogenase. Methods Mol Biol 108 (1998) 337-346
31. Packer L. alpha-Lipoic acid: a metabolic antioxidant which regulates NF- kappa B signal transduction and protects against oxidative injury. Drug Metab Rev 30 (1998) 245-275
32. Granger D.N., Vowinkel T., and Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 43 (2004) 924-931
33. Harding S.A., Sarma J., Josephs D.H., Cruden N.L., Din J.N., Twomey P.J., et al. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation 109 (2004) 1926-1929
34. Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin Cardiol 23 6 (2000) 3-7 VI
35. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., and Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78 (1991) 1760-1769
36. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., and Smith B.R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78 (1991) 1730-1737
37. Diacovo T.G., Roth S.J., Buccola J.M., Bainton D.F., and Springer T.A. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88 (1996) 146-157
38. Tuttle H.A., Davis-Gorman G., Goldman S., Copeland J.G., and McDonagh P.F. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc Diabetol 2 (2003) 12
39. Ott I., Neumann F.J., Gawaz M., Schmitt M., and Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94 (1996) 1239-1246
40. Nagata K., Tsuji T., Todoroki N., Katagiri Y., Tanoue K., Yamazaki H., et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 151 (1993) 3267-3273
41. Simon D.I., Chen Z., Xu H., Li C.Q., Dong J., McIntire L.V., et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192 (2000) 193-204
42. Neumann F.J., Marx N., Gawaz M., Brand K., Ott I., Rokitta C., et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95 (1997) 2387-2394
43. Sheikh S., and Nash G.B. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize on platelets. Blood 87 (1996) 5040-5050
44. Brown K.K., Henson P.M., Maclouf J., Moyle M., Ely J.A., and Worthen G.S. Neutrophil-platelet adhesion: relative roles of platelet P-selectin and neutrophil beta2 (DC18) integrins. Am J Respir Cell Mol Biol 18 (1998) 100-110
45. Ateghang B., Wartenberg M., Gassmann M., and Sauer H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1alpha and intracellular reactive oxygen species. J Cell Sci 119 (2006) 1043-1052
46. Condliffe A.M., Davidson K., Anderson K.E., Ellson C.D., Crabbe T., Okkenhaug K., et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106 (2005) 1432-1440
47. Subramanian K.K., Jia Y., Zhu D., Simms B.T., Jo H., Hattori H., et al. Tumor suppressor PTEN is a physiological suppressor of chemoattractant-mediated neutrophil functions. Blood (2007)
48. Clutton P., Miermont A., and Freedman J.E. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 24 (2004) 187-192